Statistics for Comparison of Major-Bleeding Risk and Health Care Costs Among Treatment-Naïve Non-Valvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivaroxaban, or Warfarin

Total visits

views
Comparison of Major-Bleeding Risk and Health Care Costs Among Treatment-Naïve Non-Valvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivaroxaban, or Warfarin 59

Total visits per month

views
August 2025 0
September 2025 0
October 2025 0
November 2025 0
December 2025 0
January 2026 0
February 2026 0

Top country views

views
United States 24
China 7
Spain 2
United Kingdom 2
Italy 2
Netherlands 2
Argentina 1
Australia 1
Brazil 1
Canada 1
Switzerland 1
Hong Kong SAR China 1
Indonesia 1
South Korea 1
New Caledonia 1
Taiwan 1
South Africa 1

Top city views

views
Ananindeua 1
Boardman 1
Buffalo 1
Chang-hua 1
Changsha 1
Florissant 1
Frugarolo 1
Guangzhou 1
Hangzhou 1
Jinan 1
Kunming 1
London 1
Madrid 1
Montreal 1
Málaga 1
Parepare 1
Posadas 1
Sakai 1
Sydney 1
Tin Shui Wai 1
Tomioka 1